These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 31696314)
1. Functional and Nonclinical Similarity of ABP 980, a Biosimilar of Trastuzumab. Jassem S; Wang W; Sweet H; Manoukian R; Chow V; Kanakaraj P; Hutterer KM; Kuhns S; Foltz IN; Chen Q; Ferbas J; McBride HJ Pharm Res; 2019 Nov; 36(12):177. PubMed ID: 31696314 [TBL] [Abstract][Full Text] [Related]
2. Totality of Scientific Evidence in the Development of ABP 980, a Biosimilar to Trastuzumab. Kolberg HC; Colleoni M; Santi P; Demetriou GS; Segui-Palmer MA; Fujiwara Y; Hurvitz SA; Hanes V Target Oncol; 2019 Dec; 14(6):647-656. PubMed ID: 31620980 [TBL] [Abstract][Full Text] [Related]
3. ABP 980: A Trastuzumab Biosimilar. Dhillon S BioDrugs; 2018 Oct; 32(5):511-514. PubMed ID: 30264234 [TBL] [Abstract][Full Text] [Related]
4. Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab. Hutterer KM; Polozova A; Kuhns S; McBride HJ; Cao X; Liu J BioDrugs; 2019 Jun; 33(3):321-333. PubMed ID: 30972630 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of action of the trastuzumab biosimilar CT-P6. Jeong SA; Choi JM; Park JM; Lee JY; Lee SJ; Lee SY; Lee SY; Park YA; Jeong HJ; Song YC; Kim SH; Chang SJ Expert Opin Biol Ther; 2019 Oct; 19(10):1085-1095. PubMed ID: 30541352 [No Abstract] [Full Text] [Related]
6. Assessment of the Molecular Mechanism of Action of SB3, a Trastuzumab Biosimilar. Paek K; Kim GW; Ahn SY; Lim JH; Jung D; Kim S; Lee JH BioDrugs; 2019 Dec; 33(6):661-671. PubMed ID: 31549311 [TBL] [Abstract][Full Text] [Related]
7. ABP 980: promising trastuzumab biosimilar for HER2-positive breast cancer. Paplomata E; Nahta R Expert Opin Biol Ther; 2018 Mar; 18(3):335-341. PubMed ID: 29350568 [TBL] [Abstract][Full Text] [Related]
8. Non-clinical similarity of biosimilar ABP 798 with rituximab reference product. McBride HJ; Jassem S; Chow V; Kanakaraj P; Lebrec H; Kuhns S; Ferbas J; Wong M; Thway TM Biologicals; 2021 Jul; 72():42-53. PubMed ID: 34303595 [TBL] [Abstract][Full Text] [Related]
10. Analytical and functional similarity of biosimilar ABP 798 with rituximab reference product. Seo N; Huang Z; Kuhns S; Sweet H; Cao S; Wikström M; Liu J Biologicals; 2020 Nov; 68():79-91. PubMed ID: 32888776 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trial. von Minckwitz G; Colleoni M; Kolberg HC; Morales S; Santi P; Tomasevic Z; Zhang N; Hanes V Lancet Oncol; 2018 Jul; 19(7):987-998. PubMed ID: 29880292 [TBL] [Abstract][Full Text] [Related]
12. Biological Characterization of SB3, a Trastuzumab Biosimilar, and the Influence of Changes in Reference Product Characteristics on the Similarity Assessment. Lee JH; Paek K; Moon JH; Ham S; Song J; Kim S BioDrugs; 2019 Aug; 33(4):411-422. PubMed ID: 31190280 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of analytical similarity between trastuzumab biosimilar CT-P6 and reference product using statistical analyses. Lee J; Kang HA; Bae JS; Kim KD; Lee KH; Lim KJ; Choo MJ; Chang SJ MAbs; 2018; 10(4):547-571. PubMed ID: 29482416 [TBL] [Abstract][Full Text] [Related]
15. Physicochemical and functional characterization of trastuzumab-dkst, a trastuzumab biosimilar. Goyal P; Iyer J; Adhikary L; Vats B; Kabadi P; Pai H; Ranayhossaini D; Gouda S; Subbarao M; Mehta G; Saha A; Bera A; Sahu A; Kaur M; Singh A; Marwah A; Reddy Moole PK; Smith J; Melarkode R; Ullanat R Future Med Chem; 2021 Sep; 13(18):1531-1557. PubMed ID: 34289749 [No Abstract] [Full Text] [Related]
16. Analytical and functional similarity of Amgen biosimilar ABP 215 to bevacizumab. Seo N; Polozova A; Zhang M; Yates Z; Cao S; Li H; Kuhns S; Maher G; McBride HJ; Liu J MAbs; 2018; 10(4):678-691. PubMed ID: 29553864 [TBL] [Abstract][Full Text] [Related]
17. Totality of Evidence Supporting the Use of ABP 980, a Trastuzumab Biosimilar: Practical Considerations. Kolberg HC; Demetriou GS; Hanes V Oncol Ther; 2021 Jun; 9(1):225-238. PubMed ID: 33428085 [TBL] [Abstract][Full Text] [Related]
19. In-Use Physicochemical and Biological Stability of the Trastuzumab Biosimilar CT-P6 Upon Preparation for Intravenous Infusion. Kim SJ; Lee JW; Kang HY; Kim SY; Shin YK; Kim KW; Oh JS; Lim KJ; Kim JY BioDrugs; 2018 Dec; 32(6):619-625. PubMed ID: 30386977 [TBL] [Abstract][Full Text] [Related]
20. Physicochemical and biological characterization of a biosimilar trastuzumab. López-Morales CA; Miranda-Hernández MP; Juárez-Bayardo LC; Ramírez-Ibáñez ND; Romero-Díaz AJ; Piña-Lara N; Campos-García VR; Pérez NO; Flores-Ortiz LF; Medina-Rivero E Biomed Res Int; 2015; 2015():427235. PubMed ID: 26075238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]